日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Obeticholic Acid Improves Cholestasis, Liver Fibrosis, and Liver Function in Patients with Primary Biliary Cholangitis with Inadequate Response to Ursodeoxycholic Acid

奥贝胆酸可改善对熊去氧胆酸治疗反应不佳的原发性胆汁性胆管炎患者的胆汁淤积、肝纤维化和肝功能。

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm15030079
Buechter, Matthias; Manka, Paul; Bulut, Kerem; Gerken, Guido; Kahraman, Alisan
发表日期：2025
文献求助 收藏

Longterm Outcome of Therapeutic Vaccination with a Third Generation Pre-S/S HBV Vaccine (PreHevbrio(R)) of Chronically HBV Infected Patients

慢性乙型肝炎病毒感染患者接受第三代前S/S型乙型肝炎疫苗（PreHevbrio®）治疗的长期疗效

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm14040364
Roggendorf, Hedwig; Shouval, Daniel; Roggendorf, Michael; Gerken, Guido
炎症/感染
肝炎
微生物学
发表日期：2024
文献求助 收藏

Factors Positively Correlated with Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B

慢性乙型肝炎患者乙型肝炎表面抗原血清转换的正相关因素

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm14040390
Buechter, Matthias; Günther, Arne Maria; Manka, Paul; Gerken, Guido; Kahraman, Alisan
肝炎
发表日期：2024
文献求助 收藏

Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis-The 20-Year Experience of a High-Volume Tertiary Center

535例自身免疫性肝炎患者的特征和长期预后——一家大型三级医疗中心20年的经验

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm12134192
Buechter, Matthias; Dorn, Dominik; Möhlendick, Birte; Siffert, Winfried; Baba, Hideo A; Gerken, Guido; Kahraman, Alisan
免疫/内分泌
肝炎
自身免疫性肝炎
发表日期：2023
文献求助 收藏

Antiviral Toll-like Receptor Signaling in Non-Parenchymal Liver Cells Is Restricted to TLR3.

非实质肝细胞中的抗病毒 Toll 样受体信号传导仅限于 TLR3

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v14020218
Werner Melanie, Schefczyk Stefan, Trippler Martin, Treckmann Juergen W, Baba Hideo A, Gerken Guido, Schlaak Joerg F, Broering Ruth
信号转导
细胞生物学
Toll-Like Receptor
Viral
发表日期：2022
文献求助 收藏

Liver Function-How to Screen and to Diagnose: Insights from Personal Experiences, Controlled Clinical Studies and Future Perspectives

肝功能——如何筛查和诊断：来自个人经验、对照临床研究和未来展望的见解

期刊:Journal of Personalized Medicine
影响因子:3
doi:10.3390/jpm12101657
Buechter, Matthias; Gerken, Guido
发表日期：2022
文献求助 收藏

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

血清甲胎蛋白与接受雷莫芦单抗治疗的晚期肝细胞癌患者的临床结局

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-021-01260-w
Zhu, Andrew X; Finn, Richard S; Kang, Yoon-Koo; Yen, Chia-Jui; Galle, Peter R; Llovet, Josep M; Assenat, Eric; Brandi, Giovanni; Motomura, Kenta; Ohno, Izumi; Daniele, Bruno; Vogel, Arndt; Yamashita, Tatsuya; Hsu, Chih-Hung; Gerken, Guido; Bilbruck, John; Hsu, Yanzhi; Liang, Kun; Widau, Ryan C; Wang, Chunxiao; Abada, Paolo; Kudo, Masatoshi
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Hippo Pathway Counter-Regulates Innate Immunity in Hepatitis B Virus Infection

Hippo通路在乙型肝炎病毒感染中反向调节先天免疫

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2021.684424
Luo, Xufeng; Zhang, Rui; Lu, Mengji; Liu, Shi; Baba, Hideo A; Gerken, Guido; Wedemeyer, Heiner; Broering, Ruth
炎症/感染
信号转导
微生物学
肝炎
Hippo
免疫/内分泌
发表日期：2021
文献求助 收藏

Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation

LiMAx测定的肝酶功能在预测TIPS植入术后无移植生存率方面优于目前的标准方法。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-021-93392-5
Rashidi-Alavijeh, Jassin; Kahraman, Alisan; Gerken, Guido; Theysohn, Jens M; Willuweit, Katharina; Hoyer, Dieter P; Lange, Christian M; Buechter, Matthias
发表日期：2021
文献求助 收藏

Clinical and functional patient characteristics predict medical needs in older patients at risk of functional decline

老年患者的临床和功能特征可预测其功能衰退风险的医疗需求。

期刊:BMC Geriatrics
影响因子:3.8
doi:10.1186/s12877-020-1443-1
Scharf, Anne-Carina; Gronewold, Janine; Dahlmann, Christian; Schlitzer, Jeanina; Kribben, Andreas; Gerken, Guido; Frohnhofen, Helmut; Dodel, Richard; Hermann, Dirk M
发表日期：2020
文献求助 收藏